lung cancer

May 29, 2015 · Amber Bauer, ASCO staff
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers. Read More >>
May 5, 2015 · Cat Snyder, ASCO staff
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer. Read More >>
April 28, 2015 · Cat Snyder, ASCO staff
Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer. Read More >>
October 9, 2014 · Jyoti Patel, MD
This weekend, Dr. Jyoti Patel will be running the Chicago Marathon to celebrate all of those with advanced lung cancer who are here “10 years strong.” During her long training runs, Dr. Patel has been able to reflect on her patients and look forward to the next great advances in lung cancer prevention and treatment. Read More >>
August 21, 2014 · Jyoti Patel, MD
Because lung cancer is associated with smoking, many people feel it is “self-inflicted.” This not only causes people to feel guilt and shame, but also leads to less research funding and fewer advances in treatment. In this guest post, Dr. Jyoti Patel talks about how the stigma of lung cancer affects the way patients are treated—both socially and medically. Read More >>

Pages